MSI-H

Oncology·MeSH: Neoplasm Metastasis

7 drugs in development·5 companies·1 clinical trial

Drug Pipeline by Phase

Approved(1)

Drug	Company
tevimbra	BeOne Medicines Ltd. (ONC)

Phase 3(3)

Phase 1(2)

Drug	Company
amg 436	AMGEN INC (AMGN)
IDE275 (GSK959)	IDEAYA Biosciences, Inc. (IDYA)

Phase 2/Phase 3(1)

Drug	Company
Actimab-A	Actinium Pharmaceuticals, Inc. (ATNM)

BioSniper tracks 7 drugs in development for MSI-H across 5 companies.

There are 1 clinical trial targeting MSI-H tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.